A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : RMPs

Search Conditions:
Search Keyword : RMPs
Search Method : Exact match.
Research Area:

Abbreviation: RMPs
Appearance Frequency: 97 time(s)
Long forms: 25

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
resting membrane potentials
(21 times)
(9 times)
ACh (3 times)
MEPPs (3 times)
EPPs (2 times)
1978 The effect of age on neuromuscular transmission.
reference measurement procedures
(18 times)
Chemistry, Clinical
(8 times)
CDC (3 times)
VDSP (3 times)
cRMP (2 times)
2010 Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 3: total thyroxine and total triiodothyronine.
red blood cell-derived microparticles
(10 times)
(5 times)
MPs (4 times)
NO (2 times)
PS (2 times)
2009 The absolute counting of red cell-derived microparticles with red cell bead by flow rate based assay.
resonant magnetic perturbations
(6 times)
(3 times)
ELM (2 times)
ELMs (2 times)
EFCC (1 time)
2010 2D soft x-ray system on DIII-D for imaging the magnetic topology in the pedestal region.
random match probabilities
(5 times)
(5 times)
STR (4 times)
LRs (2 times)
MPS (2 times)
2015 Development of a forensic identity SNP panel for Indonesia.
rural medical practitioners
(5 times)
(2 times)
ASHAs (1 time)
AWWs (1 time)
ORS (1 time)
2006 A survey of antimicrobial prescribing and dispensing practices in rural Bangladesh.
risk management plans
(4 times)
(2 times)
ADRs (1 time)
ICSRs (1 time)
MAHs (1 time)
2011 Role of the post-marketing authorisation studies in drug risk surveillance: specifications and methodologies.
Recombination mediator proteins
(3 times)
(3 times)
SSBs (2 times)
ssDNA (2 times)
BRCA2 (1 time)
1999 RMPs: recombination/replication mediator proteins.
red blood cell-derived MPs
(3 times)
(1 time)
MPs (2 times)
DENV (1 time)
NS1 (1 time)
2011 Microparticles in stored red blood cells as potential mediators of transfusion complications.
10  Risk Management Plans
(3 times)
Drug Therapy
(2 times)
EPA (1 time)
2012 Using resources for scientific-driven pharmacovigilance: from many product safety documents to one product safety master file.
11  RBC-derived microparticles
(2 times)
(1 time)
Hb (1 time)
PS (1 time)
RBC (1 time)
2016 Pleomorphic Structures in Human Blood Are Red Blood Cell-Derived Microparticles, Not Bacteria.
12  reactive mesothelial proliferations
(2 times)
Molecular Biology
(1 time)
MPM (2 times)
NNP (1 time)
2014 Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma.
13  renal mononuclear phagocytes
(2 times)
(1 time)
DCs (2 times)
AN (1 time)
IRI (1 time)
2015 Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy.
14  retinal microvascular pericytes
(2 times)
Molecular Biology
(1 time)
Ang-2 (1 time)
ECs (1 time)
P-Tie-2 (1 time)
2014 Isolation, purification, and cultivation of primary retinal microvascular pericytes: a novel model using rats.
15  Random Match Probabilities
(1 time)
(1 time)
SABs (1 time)
SNPs (1 time)
2012 Typing short amplicon binary polymorphisms: supplementary SNP and Indel genetic information in the analysis of highly degraded skeletal remains.
16  RBC microparticles
(1 time)
(1 time)
PLs (1 time)
RBC (1 time)
2013 Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality.
17  recommended management practices
(1 time)
Environmental Health
(1 time)
ECB (1 time)
GHGs (1 time)
RMS (1 time)
2006 Ecosystem carbon budgeting and soil carbon sequestration in reclaimed mine soil.
18  Red blood cell microparticles
(1 time)
(1 time)
--- 2018 Pharmacokinetics of Human Red Blood Cell Microparticles Prepared Using High-Pressure Extrusion Method.
19  red blood cell MPs
(1 time)
(1 time)
EMPs (1 time)
ET (1 time)
MPs (1 time)
2017 Clinical significance of circulating microparticles in Ph- myeloproliferative neoplasms.
20  regenerative medicine products
(1 time)
Health Services Research
(1 time)
EU (1 time)
US (1 time)
2008 Overview of the clinical application of regenerative medicine products in Japan.
21  resource management plans
(1 time)
Environmental Health
(1 time)
CBNRM (1 time)
2013 The best laid plans: community-based natural resource management (CBNRM) group capacity and planning success.
22  rifampicin-sensitive
(1 time)
Pulmonary Medicine
(1 time)
LiPA (1 time)
MDR-TB (1 time)
RMPr (1 time)
2000 Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance.
23  risk management programs
(1 time)
Drug Therapy
(1 time)
CERTs (1 time)
RM (1 time)
2005 Managing the risks of therapeutic products: proceedings of a workshop.
24  risk mitigation practices
(1 time)
Substance-Related Disorders
(1 time)
CNMP (1 time)
FNPs (1 time)
2017 Use of risk mitigation practices by family nurse practitioners prescribing opioids for the management of chronic nonmalignant pain.
25  rodent malaria parasites
(1 time)
(1 time)
--- 2005 A Plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes.